Three recognized anticavity actives
Sodium fluoride, sodium monofluorophosphate, and stannous fluoride are the only anticaries actives in the US rules for toothpaste.
No. The FDA has not approved hydroxyapatite as a cavity-fighting ingredient. The US anticaries rules recognize only three active ingredients for toothpaste: sodium fluoride, sodium monofluorophosphate, and stannous fluoride. A toothpaste without one of them can't be sold as an anticavity drug in the US.
Fluoride-free hydroxyapatite toothpaste is sold as a cosmetic. The FDA doesn't approve cosmetics before they go on sale (color additives aside), so "not FDA approved" describes the product's category, not a finding that it's unsafe. It's also why One+ makes no cavity-prevention claims.
Sodium fluoride, sodium monofluorophosphate, and stannous fluoride are the only anticaries actives in the US rules for toothpaste.
A fluoride-free hydroxyapatite toothpaste is a cosmetic in the US, so it can't claim to prevent cavities on its label.
Sangi says Japan approved its nano medical hydroxyapatite as an anticavity ingredient in 1993. That approval doesn't carry over to the US.
Shop the collection
10% nano + micro hydroxyapatite, 0 ppm fluoride, no SLS, and all 16 ingredients listed.
Not as an anticavity drug. The US anticaries rules list only fluoride actives. Fluoride-free hydroxyapatite toothpaste is sold as a cosmetic.
Yes. It's sold as a cosmetic toothpaste. It just can't make cavity-prevention drug claims.
No. The FDA doesn't preapprove cosmetics, so safety is a separate question. See is hydroxyapatite toothpaste safe.
Not for cavity protection. The ADA requires fluoride for any toothpaste that carries its Seal with a cavity-protection claim.
Sangi says Japan approved its nano medical hydroxyapatite as an anticavity ingredient in 1993. In the EU, nano-hydroxyapatite is allowed in toothpaste within set limits. See is nano-hydroxyapatite banned in Europe.